Adynamic bone disease-bone and beyond (Q40319624)

19 September 2017

0 references

Adynamic bone disease-bone and beyond (English)

1 reference

19 September 2017

Vincent M Brandenburg

series ordinal

1

1 reference

PMCID

4421169

19 September 2017

Jürgen Floege

series ordinal

2

1 reference

19 September 2017

1 June 2008

1 reference

19 September 2017

1 reference

19 September 2017

1

1 reference

19 September 2017

135-147

1 reference

19 September 2017

3

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

19 September 2017

start time

3 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Mineral metabolism disturbances in patients with chronic kidney disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Vascular calcification and fetuin-A deficiency in chronic kidney disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Vascular calcification and disordered mineral metabolism in dialysis patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Metabolic bone disease in chronic kidney disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Diagnosis of renal osteodystrophy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Development of renal bone disease.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

New insights into mineral and skeletal regulation by active forms of vitamin D.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Harnessing the parathyroids to create stronger bones

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Pathogenesis, prevention and management of low-bone turnover.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Low bone turnover in patients with renal failure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Calcific uremic arteriolopathy in association with low turnover uremic bone disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Circulating biochemical markers of bone remodeling in uremic patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Aluminium-induced bone disease in uremic rats: effect of deferoxamine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Aluminium toxicity in chronic renal insufficiency

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Aluminum and renal osteodystrophy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Low turnover bone disease.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Hyperaluminaemia from aluminum resins in renal failure.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

The dialysis encephalopathy syndrome. Possible aluminum intoxication

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Arterial calcifications and bone histomorphometry in end-stage renal disease

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Effect of aluminium on calcium-sensing receptor expression, proliferation, and apoptosis of parathyroid glands from rats with chronic renal failure

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Effect of aluminium load on parathyroid hormone synthesis.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Differences in calcium kinetic pattern between CAPD and HD patients.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Low-calcium dialysate improves mineral metabolism in hemodialysis patients

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Reversal of adynamic bone disease by lowering of dialysate calcium

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Renal osteodystrophy in diabetic patients

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4421169

Variant of adynamic bone disease in hemodialysis patients: fact or fiction?

4 November 2018

1 reference

12 December 2020

Risk of adynamic bone disease in dialyzed patients

1 reference

12 December 2020

Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro

1 reference

12 December 2020

Early therapy of renal bone disease with calcitriol: a prospective double-blind study

1 reference

12 December 2020

Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity

1 reference

12 December 2020

Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers

1 reference

12 December 2020

Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

1 reference

12 December 2020

Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis

1 reference

12 December 2020

Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate

1 reference

12 December 2020

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

12 December 2020

Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study

1 reference

12 December 2020

Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload

1 reference

12 December 2020

A sensitive stain for aluminum in undecalcified cancellous bone

1 reference

12 December 2020

Development of low-turnover bone diseases after parathyroidectomy and autotransplantation

1 reference

12 December 2020

Different patterns of renal osteodystrophy in Iberoamerica

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study

1 reference

12 December 2020

Effect of aluminum on parathyroid hormone secretion

1 reference

12 December 2020

The role of bone biopsy in the management of patients with renal osteodystrophy

1 reference

12 December 2020

Hypokinetic azotemic osteodystrophy

1 reference

12 December 2020

Risk factors for vertebral fractures in renal osteodystrophy

1 reference

12 December 2020

The relationship between basic multicellular unit activation and origination in cancellous bone

1 reference

12 December 2020

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

12 December 2020

The evolution of assays for parathyroid hormone

1 reference

12 December 2020

Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia

1 reference

12 December 2020

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy

1 reference

12 December 2020

The natural course of dialysis osteomalacia

1 reference

12 December 2020

Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy

1 reference

12 December 2020

Parathyroid and bone response of the diabetic patient to uremia

1 reference

12 December 2020

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes

1 reference

12 December 2020

Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH

1 reference

12 December 2020

Bone histologic response to deferoxamine in aluminum-related bone disease

1 reference

12 December 2020

Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis

1 reference

12 December 2020

Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining

1 reference

12 December 2020

Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure

1 reference

12 December 2020

Bone histomorphometry of renal osteodystrophy in diabetic patients

1 reference

12 December 2020

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

12 December 2020

Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol

1 reference

12 December 2020

Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome

1 reference

12 December 2020

Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients

1 reference

12 December 2020

Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDTPLUS/SFN040

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

PMCID

4421169